Skip to content

The Resilience Clinic Evaluation

The Resilience Clinic: Program Evaluation and Quality Improvement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05690256
Enrollment
87
Registered
2023-01-19
Start date
2023-05-25
Completion date
2025-06-30
Last updated
2025-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Stress, Early Life Adversity

Keywords

toxic stress, adverse childhood experiences

Brief summary

Early life adversity can affect children's physical and mental health. The Resilience Clinic is a support program for young children and their caregivers who have been exposed to significant adversity, aiming to prevent the harmful effects of stress and improve child health, behavior, and development while also reducing caregiver stress. This study seeks to evaluate the Resilience Clinic, assessing the intervention's impact on child health, behavior, and development and caregiver stress and mental health.

Detailed description

Early-life trauma and related adversities are prevalent and associated with negative health, developmental, and behavioral outcomes in children. Research to design and test practical, scalable healthcare interventions that mitigate toxic stress is needed to promote improved health and developmental outcomes in children. The Resilience Clinic is an interactive, caregiver-child psychoeducational intervention for parents and other adult caregivers of young children (ages 0-5 years) with exposure to traumatic events or other significant adversity. The aim of this primary-care based intervention is to prevent or mitigate the toxic stress response, thus promoting child resilience in the face of adversity, with the goal of improving child health, behavioral, and developmental outcomes. The overall aim of this study is to evaluate the the efficacy and operational feasibility of the revised Resilience Clinic (RC). This is a non-randomized clinical trial comparing intervention caregiver-child dyads to a prospective control group drawn from a concurrent clinical trial (NCT05259436, The Collaborative Approach to Examining Adversity and Building Resilience Study (CARE), PI Thakur). In the intervention group, we will conduct pre-post intervention comparisons along with comparisons between the intervention group and the control group drawn from the CARE study. A subgroup analysis will compare two intervention arms (clinic based vs community-based intervention) to each other and the control condition. This clinical trial is supplemented by a mixed-methods quality improvement (QI) tools, including process measures (attendance and billing/claims data) to evaluate operational and financial feasibility; participant surveys/interviews/focus groups to assess acceptability; and analysis of quality improvement meeting notes.

Interventions

BEHAVIORALResilience Clinic

A psychoeducational caregiver-child intervention based in primary care, designed to mitigate toxic stress and promote child resilience. Participants engage in 6 weekly visits in primary care using an interactive curriculum based in the evidence-based Circle of Security Parenting along with mindfulness principles.

In addition to usual pediatric primary care, enhanced primary care (the control condition for this study) provides navigational services to link to community resources based on screening for unmet social needs (e.g., food insecurity, housing, financial strain).

Sponsors

Population Health Innovation Lab
CollaboratorUNKNOWN
UCSF Benioff Children's Hospital Oakland
CollaboratorOTHER
UBCP Bancroft Pediatrics
CollaboratorUNKNOWN
Asian Health Services
CollaboratorOTHER
La Clínica de La Raza Inc.
CollaboratorOTHER
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Investigators and those analyzing outcomes will be blinded to study assignment. Given the nature of the intervention, participants and their healthcare providers will be unblinded to their assignment.

Intervention model description

non-randomized controlled trial (prospective cohort study)

Eligibility

Sex/Gender
ALL
Age
2 Years to 5 Years
Healthy volunteers
Yes

Inclusion criteria

* Caregiver: 18 years old and older, primary caregiver, English or Spanish speaking * Child: 2 to 5 years, PEARLS score \> 1 or verbal disclosure of PEARLS adversity to primary care clinician/staff

Exclusion criteria

* Caregiver: active suicidality, other psychiatric issues * Child: significant medical co-morbidities (i.e. disease requiring immunomodulators, chemo or radiation therapy, or hormonal therapy)

Design outcomes

Primary

MeasureTime frameDescription
Change in Parenting Stress Index Short Form (PSI) scorebaseline/enrollment and 2 week and 3-month follow-up after intervention ends36-item caregiver-report questionnaire validated as a measure of parenting stress (level of stress within the context of parenting). Responses indicated on a 5-point Likert scale. Higher scores indicate higher levels of parenting stress.
Change in Child Behavior Checklist (CBCL)-Preschool form total problems scale scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsCaregiver-report questionnaire validated as a measure of child behavioral challenges; part of the Achenbach System of Empirically Based Assessment (ASEBA). The CBCL-Preschool form is validated for children ages 1.5-5 years based on behavior from the prior 2 months.

Secondary

MeasureTime frameDescription
Change in Ages and Stages Questionnaire (ASQ)-3rd Edition scoresbaseline/enrollment to 3 month follow-up after intervention endsCaregiver-report questionnaire validated as a measure for risk of developmental delay in children ages 0-60 months.
Change in Caregiver depression score on the Patient Health Questionnaire (PHQ)-8 scalebaseline/enrollment and 2 week and 3-month follow-up after intervention endsQuestionnaire validated as a measure of depressive symptoms; higher scores indicate higher self-report depressive symptoms. Will be given to questionnaires to assess their depressive symptoms.
Change in Behavior Rating Inventory of Executive Function, Preschool Version (BRIEF-P) scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsCaregiver-report questionnaire, validated as a measure of executive functioning in preschool aged children (ages 2-5:11)
Change in Perceived Stress Scale (PSS) total score- Caregiver general stressbaseline/enrollment and 2 week and 3-month follow-up after intervention endsSelf-report questionnaire that measures global perceived stress based on feelings and thoughts during the last month. Higher scores indicate higher perceived stress. Will be given to caregivers as a measure of their general perceived stress.
Change in telomere length (children)baseline/enrollment to 3 month follow-up after intervention endsTelomere are nucleoproteins that protect the ends of chromosomes and can be used as a biomarker of cellular aging. Chronic stress has been associated with shorter telomere length. DNA will be extracted from cheek cells (obtained by buccal swab) in children.
Change in Caregiver anxiety score on the Generalized Anxiety Disorder (GAD) scalebaseline/enrollment and 2 week and 3-month follow-up after intervention endsQuestionnaire validated as a measure of anxiety symptoms; high scores indicate higher levels of anxiety. Will be given to caregivers to assess their anxiety symptoms.
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) global health scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsPROMIS is a set of person-centered measure evaluating the physical, mental, and social health of adults and children. This study uses the first question on the global scale, with a minimum value of 1 and maximum of 5; higher scores indicate better general health.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026